Asian Pacific Journal of Tropical Medicine · 2011 · 79 citations · 17 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyDrug DiscoveryCytotoxic ChemotherapyPharmacodynamics Of Anticancer AgentsAnticancer ActivityAnticancer ChemotherapyAnticancer Compound ScreeningAnticancer Mechanism Of ActionAnticancer Natural Products
OBJECTIVE: To investigate anticancer activity of different fractions of Tephrosia purpurea [TP] (Sharapunkha, Fabaceae) and Ficus religiosa [FR] (Peepal, Moraceae). METHODS: The fractions of TP and FR were prepared and tested for in vitro anticancer activity using human MCF 7 cell line by trypan blue exclusion method. RESULTS: The result showed that among all these fractions of TPI, TPIII, FRI and FRIII showed better anticancer activity compared to other fractions. The IC(50) value for TPI (152.4 μM), TPIII (158.71 μM), FRI (160.3 μM) and for FRIII (222.7 μM) was observed. CONCLUSIONS: The present study shows anticancer potential of TP and FR fractions in MCF 7 cell line.
17
Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
Jiří Bártek, Richard Iggo, Julian Gannon et al. · PubMed · 1990 · 606 citations
Life Sciences, Genetics, Oncology +13
Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis.
T. Fotsis, Michael S. Pepper, Stephen Breit et al. · PubMed · 1997 · 536 citations